Literature DB >> 12221406

Assessment of regional systolic and diastolic wall motion velocities in highly trained athletes by pulsed wave Doppler tissue imaging.

Sandra Zoncu1, Antonio Pelliccia, Giuseppe Mercuro.   

Abstract

We studied the relationship between left ventricular (LV) function and the increased LV mass in 18 highly trained rowing athletes (14 men, 4 women; mean age 20.7 +/- 4.5 years) using pulsed wave Doppler tissue imaging (PWDTI). Thirteen untrained volunteers, matched for age and body mass index, acted as control participants. Peak systolic, early diastolic (Ev), and late diastolic (Av) myocardial velocities (cm/s); Ev/Av ratio; and isovolumic relaxation time (ms) were measured at the level of basal lateral wall and basal posterior interventricular septum (bas-IVS) segments. In comparison with control participants, athletes showed a greater LV cavity size (P <.05), wall thickness (IVS, P <.001; posterior wall, P <.01), and mass index (P <.001). In athletes, systolic velocity of bas-IVS had increased (P <.001) and was positively correlated with IVS thickness (r = 0.66, P <.005) and LV mass index (r = 0.71, P <.001). Of the PWDTI-measured diastolic indexes, Ev/Av ratio significantly increased in athletes in comparison with control participants in both the examined segments (bas-IVS, P <.05; basal lateral wall, P <.05). When Ev and Av were separately considered, a different behavior was found in the 2 segments: Ev significantly increased in the basal lateral wall (P <.005); Av significantly decreased in the bas-IVS. The increase in the systolic velocity of bas-IVS suggests that septum greatly contributes to the longitudinal LV systolic shortening and increase of stroke volume in athletes compared with untrained participants. Moreover, the behavior of PWDTI diastolic velocities suggests a more effective relaxation activity in the longitudinal axis at the level of lateral wall. This study suggests therefore the usefulness of PWDTI in the assessment of functional properties of "athlete's heart" and differentiation from pathologic cardiac conditions.

Entities:  

Mesh:

Year:  2002        PMID: 12221406     DOI: 10.1067/mje.2002.121441

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

1.  Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults.

Authors:  André La Gerche; Andrew T Burns; Andrew J Taylor; Andrew I Macisaac; Hein Heidbüchel; David L Prior
Journal:  Eur J Appl Physiol       Date:  2011-10-01       Impact factor: 3.078

2.  Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging.

Authors:  Liangyi Qie; Xiao Meng; Yubin Wang; Min Feng; Ming Zhong; Li Li
Journal:  Clin Cardiol       Date:  2008-11       Impact factor: 2.882

3.  Diastolic function in healthy humans: non-invasive assessment and the impact of acute and chronic exercise.

Authors:  Keith P George; Louise H Naylor; Greg P Whyte; Rob E Shave; David Oxborough; Daniel J Green
Journal:  Eur J Appl Physiol       Date:  2009-10-02       Impact factor: 3.078

4.  Cardiac tissue Doppler imaging in sports medicine.

Authors:  Anne Krieg; Jürgen Scharhag; Wilfried Kindermann; Axel Urhausen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  Cardiac systolic regional function and synchrony in endurance trained and untrained females.

Authors:  Kristofer Hedman; Éva Tamás; Niclas Bjarnegård; Lars Brudin; Eva Nylander
Journal:  BMJ Open Sport Exerc Med       Date:  2015-09-14

6.  Doppler echocardiography in athletes from different sports.

Authors:  Andre Santos Moro; Marina Politi Okoshi; Carlos Roberto Padovani; Katashi Okoshi
Journal:  Med Sci Monit       Date:  2013-03-12

Review 7.  The role of new echocardiographic techniques in athlete's heart.

Authors:  Antonello D'Andrea; Eduardo Bossone; Juri Radmilovic; Pio Caso; Raffaele Calabrò; Maria Giovanna Russo; Maurizio Galderisi
Journal:  F1000Res       Date:  2015-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.